Clinical spectrum of impulse control disorders in Parkinson's disease

Movement Disorders

Volumn 30, Issue 2, 2015, Pages 121-127

  Weintraub, Daniel ^a,b   David, Anthony S ^c   Evans, Andrew H ^d   Grant, Jon E ^e   Stacy, Mark ^f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

^e UNIVERSITY OF CHICAGO   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine agonists; Impulse control disorder; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ANHEDONIA; APATHY; BINGE EATING DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; COMPULSIVE PERSONALITY DISORDER; CULTURAL FACTOR; DAYTIME SOMNOLENCE; HUMAN; IMPULSE CONTROL DISORDER; IMPULSIVENESS; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; STRUCTURED INTERVIEW; WITHDRAWAL SYNDROME;

EID: 84964267888     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26016     Document Type: Review

References (77)

1. Schreiber L, Odlaug B, Grant J. Impulse control disorders: updated review of clinical characteristics and pharmacologial management. Front Psychiatry 2011;2:1-11.
2. Holden C. 'Behavioral' addictions: do they exist? Science 2001;294:980-982.
3. Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009;61:502-510.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing; 2013.
5. Okai D, Samuel M, Askey-Jones S, et al. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework. Eur J Neurol 2011;18:1379-1383.
6. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-1096.
7. Voon V, Sohr M, Lang AE, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011;69:986-996.
8. Phu A, Xu Z, Brakoulias V, et al. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients. J Clin Neurosci 2014;21:63-66.
9. Leroi I, Harbishettar V, Andrews M, et al. Carer burden in apathy and impulse control disorders in Parkinson's disease. Int J Geriatr Psychiatry 2012;27:160-166.
10. Giovannoni G, O'Sullivan JD, Turner K, et al. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-428.
11. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
12. O'Sullivan SS, Djamshidian A, Evans AH, et al. Excessive hoarding in Parkinson's disease. Mov Disord 2010;25:1026-1033.
13. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627.
14. Grant JE, Levine L, Kim D, et al. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 2005;162:2184-2188.
15. Hodgins DC, Stea JN, Grant, JE. Gambling disorders. Lancet 2011;378:1874-1884.
16. Koran LM, Faber RJ, Aboujaoude E, et al. Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry 2006;163:1806-1812.
17. Kuzma JM, Black DW. Epidemiology, prevalence, and natural history of compulsive sexual behavior. Psychiatr Clin North Am 2008;31:603-611.
18. Smink FR, van Hoeken D, Hoek HW. Epidemiology, course, and outcome of eating disorders. Curr Opin Psychiatry 2013;26:543-548.
19. Giladi N, Weitzman N, Schreiber S, et al. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol (Oxf) 2007;21:501-506.
20. Avanzi M, Baratti M, Cabrini S, et al. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006;21:2068-2072.
21. Perez-Lloret S, Rey M, Fabre N, et al. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clin Neuropharmacol 2012;35:261-265.
22. Willis A, Schootman M, Kung N, et al. Epidemiology and neuropsychiatric manifestations of young onset Parkinson's disease in the United States. Parkinsonism Relat Disord 2013;19:202-206.
23. de Chazeron I, Llorca PM, Chéreau-Boudet I, et al. Hypersexuality and pathological gambling in Parkinson's disease: a cross-sectional case-control study. Mov Disord 2011;26:2127-2130.
24. Antonini A, Siri C, Santangelo G, et al. Impulsivity and compulsivity in drug-naive patients with Parkinson's disease. Mov Disord 2011;26:464-468.
25. Ishihara L, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 2006;21:1066-1072.
26. Arabia G, Grossardt BR, Colligan RC, et al. Novelty seeking and introversion do not predict the long-term risk of Parkinson disease. Neurology 2010;75:349-357.
27. Callesen MB, Scheel-Krüger J, Kringelbach ML, et al. A systematic review of impulse control disorders in Parkinson's disease. J Parkinsons Dis 2013;3:105-138.
28. Voon V, Hassan K, Zurowski M, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257.
29. Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol 2008;64(Suppl):S93-S100.
30. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-973.
31. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathological gambling and medication association in Parkinson disease. Neurology 2006;66:1750-1752.
32. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524-529.
33. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
34. Hassan A, Bower JH, Kumar N, et al. Dopamine agonist-triggered pathologicla behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord 2011;17:260-264.
35. Lee JY, Kim JM, Kim JW, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010;16:202-207.
36. Lim SY, Tan ZK, Ngam PI, et al. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: assessment using the QUIP. Parkinsonism Relat Disord 2011;17:761-764.
37. Fan WH, Ding H, Ma JH, et al. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett 2009;465:6-9.
38. Chiang H, Huang Y, Chen S, et al. Are there ethnic differences in impulsive/compulsive behaviors in Parkinson's disease? Eur J Neurol 2014;19:494-500.
39. Joutsa J, Martikainen K, Vahlberg T, et al. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord 2012;18:155-160.
40. Callesen M, Weintraub D, Damholdt M, et al. Impulsive and compulsive behaviors among Danish patients with Parkinson's disease: prevalence, depression, and personality. Parkinsonism Relat Disord 2014;20:22-26.
41. Valenca G, Glass P, Negreiros N, et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 2013;19:698'700.
42. Sarathchandran P, Soman S, Sarma G, et al. Impulse control disoder and related behaviors in Indian patients with Parkinson's disease. Mov Disord 2013;28:1901-1902.
43. Rohde K, Riedel O, Lueken U, et al. Impulsive-compulsive behaviours in a German Parkinson's disease outpatient sample. Fortschr Neurol Psychiatr 2013;81:503-510.
44. Garcia-Ruiz P, Castrillo J, Alonso-Canovas A, et al. Impulse control disorders in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry 2014;85:840-844.
45. Nikitina A, Fedorova N. Impulsive-compulsive syndrome in Parkinson's disease. Zh Nevrol Psikhiatr Im S S Korsakova 2013;113:32-38.
46. Hurt C, Alkufri F, Brown R, et al. Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease. J Parkinsons Dis 2014;4:245-254.
47. Rodríguez-Violante M, González-Latapi P, Cervantes-Arriaga A, Camacho-Ordoñez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson's disease patients. Parkinsonism Relat Disord 2014;20:907-910.
48. Miyasaki J, Hassan KL, Lang AE, et al. Punding prevalence in Parkinson's disease. Mov Disord 2007;22:1179-1181.
49. Bastiaens J, Dorfman BJ, Christos PJ, et al. Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord 2013;28:327-333.
50. Weintraub D, Sohr M, Potenza MN, et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 2010;68:963-968.
51. Ondo W, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008;14:28-32.
52. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 2009;25:425-431.
53. Poletti M, Logi C, Lucetti C, et al. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson's disease: association with dopaminergic drugs. J Clin Psychopharmacol 2013;33:691-694.
54. Kurlan R. Disabling repetitive behaviors in Parkinson's disease. Mov Disord 2004;19:433-437.
55. Nicoletti A, Luca A, Raciti L, et al. Obsessive compulsive personality disorder and Parkinson's disease. PLoS One 2013;8:e54822.
56. O'Sullivan S, Loane C, Lawrence A, et al. Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease. J Neurol Neurosurg Psychiatry 2011;82:620-622.
57. Scullin M, Sollinger A, Land J, et al. Sleep and impulsivity in Parkinson's disease. Parkinsonism Relat Disord 2013;19:991-994.
58. Pettorruso M, Martinotti G, Fasano A, et al. Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study. Psychiatry Res 2014;215:448-452.
59. Ardouin C, Chereau I, Llorca P, et al. Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease. Rev Neurol 2009;175:845-856.
60. Leroi I, Andrews M, McDonald K, et al. Apathy and impulse control disorders in Parkinson's disease: a direct comparison. Parkinsonism Relat Disord 2012;18:198-203.
61. Thobois S, Ardouin C, Lhommée E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133:1111-1127.
62. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010;67:58-63.
63. Maier F, Merkl J, Ellereit A, et al. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease. Parkinsonism Relat Disord 2014;20:421-427.
64. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007;22:1757-1763.
65. Avila A, Cardona X, Martin-Baranera M, et al. Does nefazodone improve both depression and Parkinson disease? A pilot randomized trial. J Clin Psychopharmacol 2003;23:509-513.
66. Goerlich-Dobre K, Probst C, Winter L, Witt K, Deuschl G, Möller B, van Eimeren T. Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2014;29:214-220.
67. Papay K, Mamikonyan E, Siderowf AD, et al. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord 2011;17:153-155.
68. Hirsch ES, Adler G, Amspoker AB, et al. Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. J Parkinsons Dis 2013;3:55-60.
69. Christenson GA, Faber RJ, deZwaan M. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994;55:5-11.
70. Weintraub D, Stewart S, Shea JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Behaviors in Parkinson's Disease (QUIP). Mov Disord 2009;24:1461-1467.
71. Weintraub D, Mamikonyan E, Papay K, et al. Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale. Mov Disord 2012;27:242-247.
72. Cabrini S, Baratti M, Bonfà F, Cabri G, Uber E, Avanzi M. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease. Neurol Sci 2009;30:307-313.
73. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and climimetric testing results. Mov Disord 2008;23:2129-2170.
74. Goetz CG, Tilley BC, Stebbins GT. Dopamine dysregulation syndrome item from the MDS-UPDRS. Mov Disord 2012;27:166.
75. du Toit P, van Kradenburg J, Niehaus D, et al. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 2001;42:291-300.
76. Lhommée E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviors. Brain 2012;135:1463-1477.
77. Okai D, Askey-Jones S, Mack J, et al. Parkinson's Impulse Control Scale (PICS) for the rating of severity of impulsive compulsive behaviors in Parkinson's disease. Mov Disord 2014 (in press).